Corcept Therapeutics Incorporated
CORT
$73.06
-$3.59-4.68%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 421.68M | 342.23M | 322.76M | 383.33M | 380.34M |
| Total Receivables | 69.63M | 64.57M | 61.82M | 53.98M | 62.62M |
| Inventory | 12.35M | 12.28M | 14.37M | 12.41M | 8.05M |
| Prepaid Expenses | 22.98M | 9.69M | 8.55M | 9.49M | 15.98M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 14.49M | 14.35M | 31.00M | 12.39M | -- |
| Total Current Assets | 541.13M | 443.11M | 438.50M | 471.60M | 466.98M |
|
|
|||||
| Total Current Assets | 541.13M | 443.11M | 438.50M | 471.60M | 466.98M |
| Net Property, Plant & Equipment | 6.87M | 7.31M | 7.69M | 8.01M | 8.43M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 173.05M | 178.52M | 152.22M | 141.11M | 141.54M |
| Total Assets | 823.61M | 801.72M | 846.46M | 840.55M | 784.26M |
|
|
|||||
| Total Accounts Payable | 34.45M | 23.53M | 27.95M | 15.38M | 18.58M |
| Total Accrued Expenses | 125.86M | 113.24M | 110.11M | 122.11M | 99.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.05M | 1.02M | 984.00K | 829.00K | 432.00K |
| Total Finance Division Other Current Liabilities | 10.91M | 6.88M | 4.03M | 2.46M | 7.30M |
| Total Other Current Liabilities | 10.91M | 6.88M | 4.03M | 2.46M | 7.30M |
| Total Current Liabilities | 172.27M | 144.66M | 143.07M | 140.77M | 126.22M |
|
|
|||||
| Total Current Liabilities | 172.27M | 144.66M | 143.07M | 140.77M | 126.22M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.31M | 5.59M | 5.85M | 6.11M | 6.36M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.13M | 15.68M | 14.25M | 14.08M | 12.85M |
| Total Liabilities | 191.71M | 165.93M | 163.17M | 160.96M | 145.42M |
|
|
|||||
| Common Stock & APIC | 933.75M | 901.00M | 863.00M | 832.24M | 806.45M |
| Retained Earnings | 619.10M | 599.43M | 564.28M | 543.74M | 512.99M |
| Treasury Stock & Other | -920.95M | -864.64M | -744.00M | -696.39M | -680.61M |
| Total Common Equity | 631.90M | 635.79M | 683.29M | 679.59M | 638.84M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 631.90M | 635.79M | 683.29M | 679.59M | 638.84M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 631.90M | 635.79M | 683.29M | 679.59M | 638.84M |
|
|
|||||